
Mitochondrial metabolic optimizer
Virtual consult required
This peptide requires a brief virtual visit before our team can prescribe.
Virtual Consult
Our licensed provider reviews your health profile via secure video — typically 10 minutes. Required for any peptide prescription.
Refund Policy: If found not eligible due to health reasons after consultation, you will receive a full refund.
MOTS-c is a 16-amino acid peptide encoded by mitochondrial DNA that acts as a metabolic regulator through mitochondrial-nuclear signaling. It activates the AMPK pathway—the body's "metabolic master switch"—promoting glucose uptake independent of insulin, enhancing fatty acid oxidation, and improving mitochondrial function. MOTS-c also reduces adipose tissue inflammation and prevents age-related insulin resistance.
Discovered in 2015, MOTS-c naturally declines with age, contributing to metabolic dysfunction and insulin resistance. Research shows it mimics beneficial effects of exercise and caloric restriction at the molecular level. Genetic variants in the MOTS-c coding region are associated with exceptional longevity, particularly in Japanese centenarians.
MOTS-c shows promise for metabolic syndrome, type 2 diabetes, obesity, and age-related decline. Research demonstrates its ability to reverse insulin resistance, reduce body fat, and improve exercise capacity. The peptide is also being investigated for protecting against sarcopenia and neurodegenerative conditions.
Backed by peer-reviewed research from leading medical journals